| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/PAI.12197 |
| P698 | PubMed publication ID | 24438133 |
| P2093 | author name string | Pakit Vichyanond | |
| Uwe Pleyer | |||
| Punchama Pacharn | |||
| Andrea Leonardi | |||
| P2860 | cites work | Vernal keratoconjunctivitis in an Israeli group of patients and its treatment with sodium cromoglycate | Q33641705 |
| Ocular complications of topical, peri-ocular, and systemic corticosteroids | Q34120572 | ||
| Vernal keratoconjunctivitis: pathogenesis and treatment | Q34674419 | ||
| Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis | Q34824549 | ||
| A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis | Q35171524 | ||
| Vernal keratoconjunctivitis in school children in Rwanda and its association with socio-economic status: a population-based survey | Q35246102 | ||
| Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis | Q35298118 | ||
| Corticosteroid-induced glaucoma: a review of the literature | Q36118249 | ||
| Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients | Q36172375 | ||
| Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis | Q36374039 | ||
| Clinical grading of vernal keratoconjunctivitis. | Q36943531 | ||
| Rhinovirus wheezing illness and genetic risk of childhood-onset asthma | Q37128812 | ||
| A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis | Q37306385 | ||
| Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids: in search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis | Q37780934 | ||
| The hygiene hypothesis revisited: role of materno-fetal interactions | Q37784446 | ||
| Respiratory syncytial virus and chlamydia are not detectable by PCR in ongoing vernal keratoconjunctivitis | Q37872205 | ||
| Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. | Q38040514 | ||
| Vernal keratoconjunctivitis: an update | Q38049578 | ||
| Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis | Q38102592 | ||
| Antiallergic activity of topical lodoxamide on in vivo and in vitro models. | Q41146649 | ||
| Cromolyn Effects on Vernal Keratoconjunctivitis in Children | Q41346571 | ||
| Immunopathogenesis of conjunctival remodelling in vernal keratoconjunctivitis | Q42475067 | ||
| Corneal confocal microscopy in patients with vernal keratoconjunctivitis | Q42499108 | ||
| Topical tacrolimus 0.03% monotherapy for vernal keratoconjunctivitis--case series | Q43014231 | ||
| Olopatadine inhibits anti-immunoglobulin E-stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunctival epithelial cells | Q43813384 | ||
| Management, clinical outcomes, and complications of shield ulcers in vernal keratoconjunctivitis. | Q44105299 | ||
| Vernal keratoconjunctivitis: Result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment. | Q44758842 | ||
| Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years | Q45747463 | ||
| Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study | Q46502349 | ||
| Epinastine hydrochloride antagonism against interleukin-4-mediated T cell cytokine imbalance in vitro | Q46988741 | ||
| Vernal keratoconjunctivitis in school children in Rwanda: clinical presentation, impact on school attendance, and access to medical care | Q47644662 | ||
| Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. | Q50761215 | ||
| Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study. | Q50782281 | ||
| Evaluation of the corneal topographic characteristics of keratoconus with orbscan II in patients with and without atopy. | Q50926853 | ||
| Estrogen and progesterone receptors in vernal keratoconjunctivitis. | Q50962855 | ||
| Vernal keratoconjunctivitis with limbal stem cell deficiency. | Q51032315 | ||
| Keratoconus: matrix metalloproteinase-2 activation and TIMP modulation. | Q51253364 | ||
| Staphylococcal enterotoxin induced IL-5 stimulation as a cofactor in the pathogenesis of atopic disease: the hygiene hypothesis in reverse? | Q51680824 | ||
| Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. | Q51819157 | ||
| Allergen immunotherapy: a practice parameter third update. | Q52712682 | ||
| Combined medical and surgical treatment of severe vernal keratoconjunctivitis. | Q54033509 | ||
| Efficacy of mipragoside ophthalmic gel in vernal keratoconjunctivitis. | Q54357052 | ||
| Alterations of the ocular surface epithelial mucins 1, 2, 4 and the tear functions in patients with atopic keratoconjunctivitis. | Q54566513 | ||
| P433 | issue | 4 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 314-322 | |
| P577 | publication date | 2014-01-20 | |
| P1433 | published in | Pediatric Allergy & Immunology | Q14064731 |
| P1476 | title | Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes | |
| P478 | volume | 25 |
| Q38909557 | An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis. |
| Q40267943 | Chaperone patterns in vernal keratoconjunctivitis are distinctive of cell and Hsp type and are modified by inflammatory stimuli |
| Q37712361 | Clinical and allergological analysis of ocular manifestations of sick building syndrome |
| Q93271815 | Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score |
| Q42394382 | Comment on: Systemic approach to managing vernal conjunctivitis in clinical practice and severity grading system and treatment algorithm |
| Q34386763 | Conjunctival epithelial and goblet cell function in chronic inflammation and ocular allergic inflammation |
| Q47109315 | Decreased incidence of glaucoma in children with asthma using inhaled corticosteroid: a cohort study |
| Q36206872 | Dry Eye in Vernal Keratoconjunctivitis: A Cross-Sectional Comparative Study. |
| Q37264048 | Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis |
| Q92239862 | Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children |
| Q90344139 | Management of vernal keratoconjunctivitis in children in Saudi Arabia |
| Q38517653 | Off-Label Uses of Omalizumab. |
| Q90223161 | Pattern of steroid misuse in vernal keratoconjunctivitis resulting in steroid induced glaucoma and visual disability in Indian rural population: An important public health problem in pediatric age group |
| Q57048591 | Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model |
| Q51753447 | Serum Vitamin D Levels in Children with Vernal Keratoconjunctivitis. |
| Q38809512 | Treatment of allergic children - Where is the progress (for the practicing allergist)? |
| Q98288705 | Vernal Keratoconjunctivitis: A Case of Anti-IgE Treatment with Short-Lasting Remission |
| Q64270516 | Vernal Keratoconjunctivitis: an update focused on clinical grading system |
| Q47650856 | Vitamin D levels in children affected by vernal keratoconjunctivitis |
| Q52870532 | [Vernal keratoconjunctivitis]. |
Search more.